We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Study Critiques Evidence Used in FDA Opioid Approvals
Study Critiques Evidence Used in FDA Opioid Approvals
In recent years, the FDA has tended to approve new opioid drugs “on the basis of pivotal trials of short or intermediate duration, often in narrowly defined pain populations of patients who could tolerate the drug,” according to a new study led by researchers at the Johns Hopkins School of Public Health.